Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Business
Will Meakin-Durrant

AstraZeneca to inject £300 million into UK in surprise U-turn

Pharmaceutical giant AstraZeneca is set to inject £300 million into UK drug development after halting a £200 million expansion and vaccine plant last year.

The investment follows praise from drugmakers including AstraZeneca for a US-UK agreement aimed at increasing medicine prices in Britain in line with the Trump administration's new US pricing policies. The deal was finalised earlier in April.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.